Bronchial Diseases: Clinical Trials

6,272 trials for Bronchial Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4087 completed, 768 unknown, 477 recruiting, 387 terminated. 1729 Not applicable, 1021 Phase 2, 826 Phase 3, 605 Phase 4, 553 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1729Completed 1062, Unknown 271, Recruiting 148, Terminated 79, Not yet recruiting 67, Withdrawn 51, Active not recruiting 36, Enrolling by invitation 9, Suspended 6
Phase 21021Completed 680, Terminated 104, Recruiting 71, Unknown 66, Withdrawn 52, Active not recruiting 32, Not yet recruiting 10, Enrolling by invitation 4, Suspended 2
Phase 3826Completed 622, Terminated 61, Unknown 46, Recruiting 43, Withdrawn 26, Active not recruiting 15, Not yet recruiting 11, Enrolling by invitation 1, Suspended 1
Phase 4605Completed 406, Unknown 74, Terminated 51, Recruiting 28, Withdrawn 21, Active not recruiting 12, Not yet recruiting 10, Enrolling by invitation 3
Phase 1553Completed 404, Terminated 50, Recruiting 30, Unknown 25, Withdrawn 19, Active not recruiting 18, Not yet recruiting 6, Suspended 1
Early Phase 138Completed 21, Terminated 4, Recruiting 3, Unknown 3, Withdrawn 3, Active not recruiting 2, Enrolling by invitation 2

Follow Bronchial Diseases: new trials by email Literature Review of Bronchial Diseases trials Research Report on Bronchial Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)
linvemastat, Placebo - Asthma (Diagnosis), Pulmonary Function
Phase 2Not yet recruitingForesee Pharmaceuticals Co., Ltd.1352027-03-012026-07-20
Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease
Biospecimen Collection, Mindfulness Relaxation, Survey Administration - Chronic Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm
Not applicableRecruitingCity of Hope Medical Center172027-03-012026-10-16
Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
HDM sublingual Immunotherapy, Placebo - Asthma, Allergy
Phase 2WithdrawnBoston Children's Hospital2027-02-012024-11-26
Prevent Wheeze Trial
Dexamethasone 0.6 mg/kilogram body weight single dose, Placebo - Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing
Phase 4Not yet recruitingNorwegian University of Science and Technology4862027-02-012026-10-05
Educational Needs of Patients With Severe Asthma on Targeted Immunotherapies
Initial assesment interwiew, Intake Interview with the Patient - Severe Asthma
Not yet recruitingUniversity Hospital, Angers202027-01-042026-10-02
Repeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Metered cryospray (MCS) - COPD (Chronic Obstructive Pulmonary Disease), Chronic Bronchitis
Not applicableNot yet recruitingCSA Medical, Inc.102027-01-022026-10-05
Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )
Slow Release DHEA, Placebo - Asthma
Phase 2Not yet recruitingIndiana University302027-01-012026-02-27
Nebulized Ketamine for Severe Asthma Attacks in Children
Ketamine (1 mg/kg), Placebo - Asthma Acute, Exacerbation of Allergic Asthma
Phase 2Not yet recruitingSultan Qaboos University602027-01-012026-07-27
Multimodal Stewardship Programme to Improve Antibiotic Prescribing for Children With Lower Respiratory Tract Infections
PRACTICE-LRTI multimodal antimicrobial stewardship programme - Bronchitis, Acute, Community-acquired Pneumonia
Not applicableNot yet recruitingTampere University500002027-01-012026-10-26
Sustained Asthma Remission and Reduced Relapse Using a Comprehensive Management Strategy (SARRE-COMS)
Comprehensive Biomarker-Guided Management Strategy, Standard of Care - Asthma (Diagnosis)
Not applicableNot yet recruitingHana Serajeddini502026-12-022026-09-25
Allergy, Asthma, and Atopic Eczema in Finland
No intervention, No Intervention: Observational Cohort - Asthma, Asthma in Children
Not yet recruitingTampere University12000002026-12-012026-10-15
Development and Validation of the Indian Asthma Care Bundle for Reducing Readmission and Improving Post-hospitalisation Care After Discharge From Hospital Due to an Acute Asthma Exacerbation
Indian Asthma Care Bundle (I-ACB) - Asthma Exacerbation, Asthma (Diagnosis)
Not applicableNot yet recruitingAhmedabad University2602026-12-012026-09-11
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
Severe Asthma, Chronic Rhinosinusitis With Nasal Polyps(CRSwNP)
Not yet recruitingAstraZeneca2102026-11-282026-06-04
Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma
CHF5993 100/6/12.5 μg pMDI HFA-152a, Seretide Evohaler - Asthma
Phase 3Not yet recruitingChiesi Farmaceutici S.p.A.7002026-11-162026-10-05
The LalelaLung Study: Digital Stethoscope Clinical Evaluation
StethoMe AI-enabled digital stethoscope system, Standard IMCI assessment - Pneumonia, Tuberculosis, Pulmonary
Phase 4Not yet recruitingJohns Hopkins University3502026-11-022026-09-23
Changing Lifestyle to Improve Quality of Life in Spanish Adolescents With Asthma
Lifestyle-change intervention - Asthma (Diagnosis)
Not applicableNot yet recruitingUniversitat Internacional de Catalunya962026-11-022026-10-22
A Study to Evaluate the Efficacy and Safety of CHF10196 Tablets (Florensocatib) Compared With Placebo in Male and Female Participants 12 to 85 Years of Age With Bronchiectasis
CHF10196 tablets (florensocatib), Placebo - Bronchiectasis
Phase 3Not yet recruitingChiesi Farmaceutici S.p.A.9042026-11-012026-06-24
Validation of 1 Minute Sit-to Stand Test for Assessment of Breathlessness at Exertion in Individuals With Chronic Lung Disease
1MSTS - COPD (Chronic Obstructive Pulmonary Disease), Asthma (Diagnosis)
Not yet recruitingJacob Sandberg1202026-11-012026-09-23
Anakinra Rescue Treatment for Moderate Asthma Attacks (ARTMA)
Anakinra 100 Mg/0.67 Ml Inj Syringe, Saline Placebo/0.67 Ml Inj Syringe - Asthma (Diagnosis), Persistent Asthma
Phase 1Not yet recruitingUniversity of North Carolina, Chapel Hill602026-11-012026-07-15
Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate
Fluticasone Propionate, Water Mouthwash, EVOOW Mouthwash - Asthma
Phase 4Not yet recruitingUniversity of Wisconsin, Madison202026-11-012026-09-24

Showing 20 of 6272. Sign in to see all of them.

Narrower conditions

Asthma (4460)  ·  Bronchiolitis Obliterans Syndrome (703)  ·  Pulmonary Disease, Chronic Obstructive (664)  ·  Bronchiectasis (330)  ·  Bronchiolitis (261)  ·  Lung Diseases (225)  ·  Bronchitis, Chronic (201)  ·  Hypersensitivity (191)  ·  Bronchitis (146)  ·  Rhinitis, Allergic (125)  ·  Emphysema (116)  ·  Respiratory Tract Diseases (101)  ·  Disease (96)  ·  Inflammation (95)  ·  Obesity (95)

Broader conditions

Respiratory Tract Diseases (6171)  ·  Lung Diseases, Obstructive (5747)  ·  Lung Diseases (5700)  ·  Immune System Diseases (5247)  ·  Hypersensitivity, Immediate (4538)  ·  Respiratory Hypersensitivity (4507)  ·  Hypersensitivity (4374)  ·  Pathological Conditions, Signs and Symptoms (1605)  ·  Bronchitis (1222)  ·  Pathologic Processes (1106)  ·  Infections (881)  ·  Disease Attributes (866)  ·  Bronchiolitis (788)  ·  Chronic Disease (787)

Interventions

Budesonide (179)  ·  Fluticasone (176)  ·  Albuterol (167)  ·  montelukast (159)  ·  Formoterol Fumarate (129)  ·  Fluticasone-Salmeterol Drug Combination (89)  ·  Salmeterol Xinafoate (83)  ·  Budesonide, Formoterol Fumarate Drug Combination (82)  ·  Beclomethasone (77)  ·  Omalizumab (70)  ·  Azithromycin (52)  ·  mepolizumab (50)  ·  benralizumab (49)  ·  Saline Solution (45)  ·  Tiotropium Bromide (42)

Sponsors

AstraZeneca (346)  ·  GlaxoSmithKline (280)  ·  Novartis Pharmaceuticals (94)  ·  National Heart, Lung, and Blood Institute (NHLBI) (85)  ·  Organon and Co (69)  ·  Boehringer Ingelheim (68)  ·  Chiesi Farmaceutici S.p.A. (66)  ·  Imperial College London (52)  ·  Sanofi (49)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (48)  ·  Assistance Publique - Hôpitaux de Paris (46)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (45)  ·  Brigham and Women's Hospital (44)  ·  University of North Carolina, Chapel Hill (44)  ·  Johns Hopkins University (38)

Countries

United States (2197)  ·  United Kingdom (697)  ·  Canada (563)  ·  Germany (514)  ·  France (448)  ·  China (386)  ·  Spain (347)  ·  Poland (317)  ·  Italy (280)  ·  Netherlands (228)  ·  South Korea (218)  ·  Belgium (207)  ·  Turkey (Türkiye) (206)  ·  Australia (201)  ·  Russia (191)

Top investigators

Louis-Philippe Boulet, MD (20)  ·  Elliot Israel, MD (15)  ·  Esther Garcia, MD (12)

Results publications

PMID 36472162, PMID 27881132, PMID 37010196, PMID 39393433, PMID 31319851, PMID 29400693, PMID 35691614, PMID 33217063, PMID 38127464, PMID 26704701, PMID 30954640, PMID 32816215, PMID 33305842, PMID 22329608, PMID 24184147, PMID 28065396, PMID 29174062, PMID 29536781, PMID 32180164, PMID 33289613, PMID 34098955, PMID 35636689, PMID 10573240, PMID 14713908, PMID 20075384, PMID 20851928, PMID 21060320, PMID 24838406, PMID 24966061, PMID 26369589, PMID 26498386, PMID 26612545, PMID 28889110, PMID 30802500, PMID 30876830, PMID 31047111, PMID 31251094, PMID 31447130, PMID 31613151, PMID 31760132, PMID 31798645, PMID 32071136, PMID 32298853, PMID 33223095, PMID 33369570, PMID 33465457, PMID 33710614, PMID 35287231, PMID 36253275, PMID 36356712

NIH funding

2015 (36), 2016 (35), 2009 (29), 2014 (28), 2023 (28), 2018 (25), 2017 (23), 2019 (21), 2025 (21), 2008 (13), U10HL098115 (8), U10HL074212 (6), P01HL107202 (5), R01HL135235 (5), U10HL064287 (5)